Coeptis Therapeutics Holdings, Inc. (ZSQR) Balance sheet
Market cap
$57.63M
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 907,184 | 404,345 | 4 | 1 | 532,885 |
| Total cash & short-term investments | 907,184 | 404,345 | 4 | 1 | 532,885 |
| Accounts receivable, net | - | - | 8,075 | - | - |
| Total current assets | 958,999 | 412,678 | 4 | 5 | 1 |
| Property, plant and equipment, net | - | - | 12,542 | 11,306 | 10,460 |
| Marketable securities, non-current | 76 | 76 | - | - | - |
| Total non-current assets | 76 | 76 | 4 | 3 | 8 |
| Total assets | 77 | 76 | 8 | 8 | 9 |
| Accounts payable | - | - | 99,021 | 1 | 1 |
| Total current liabilities | 5,000 | 139,927 | 2 | 3 | 5 |
| Long-term debt, non-current | - | - | 150,000 | 150,000 | - |
| Total non-current liabilities | 2 | 7 | 1 | 768,429 | 528,125 |
| Total liabilities | 2 | 7 | 3 | 4 | 5 |
| Common stock and paid-in capital | 25,000 | 30 | 71 | 92 | 103 |
| Retained earnings | -76,533 | -6,799,249 | -65,739,723 | -87,356,260 | -98,233,673 |
| Stockholders' equity | 5 | -6,774,249 | 5 | 4 | 4 |
| Total debt | - | - | 150,000 | 150,000 | - |
| Net debt | - | - | -3,641,302 | -1,319,134 | - |
| D/E ratio (%) | - | - | 3.1 | 3.5 | - |